- call +1-201-465-4211
- email sales@mrinsights.biz
Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
Scope of the Report:
This report focuses on the Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.
The worldwide market for Human Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
B. Braun
Becton, Dickinson
Biocon
Biodel
ELI Lilly
Julphar
NOVO Nordisk
Sanofi
Wockhardt
Ypsomed
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Insulin Analogs and Biosimilars
Human Insulin Biologics
Market Segment by Applications, can be divided into
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
There are 15 Chapters to deeply display the global Human Insulin market.
Chapter 1, to describe Human Insulin Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Insulin, with sales, revenue, and price of Human Insulin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Insulin, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Insulin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Human Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Insulin Analogs and Biosimilars
1.2.2 Human Insulin Biologics
1.3 Market Analysis by Applications
1.3.1 Short acting
1.3.2 Intermediate acting
1.3.3 Long acting
1.3.4 Pre-mix Insulin
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 B. Braun
2.1.1 Business Overview
2.1.2 Human Insulin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Becton, Dickinson
2.2.1 Business Overview
2.2.2 Human Insulin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocon
2.3.1 Business Overview
2.3.2 Human Insulin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biodel
2.4.1 Business Overview
2.4.2 Human Insulin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 ELI Lilly
2.5.1 Business Overview
2.5.2 Human Insulin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Julphar
2.6.1 Business Overview
2.6.2 Human Insulin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 NOVO Nordisk
2.7.1 Business Overview
2.7.2 Human Insulin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Human Insulin Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Wockhardt
2.9.1 Business Overview
2.9.2 Human Insulin Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ypsomed
2.10.1 Business Overview
2.10.2 Human Insulin Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Insulin Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Human Insulin Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Insulin Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Insulin Manufacturer Market Share in 2017
3.3.2 Top 6 Human Insulin Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Human Insulin Market Analysis by Regions
4.1 Global Human Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Insulin Sales and Market Share by Regions (2013-2018)
4.1.2 Global Human Insulin Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Insulin Sales and Growth Rate (2013-2018)
4.3 Europe Human Insulin Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Insulin Sales and Growth Rate (2013-2018)
4.5 South America Human Insulin Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Insulin Sales and Growth Rate (2013-2018)
5 North America Human Insulin by Countries
5.1 North America Human Insulin Sales, Revenue and Market Share by Countries
5.1.1 North America Human Insulin Sales and Market Share by Countries (2013-2018)
5.1.2 North America Human Insulin Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Insulin Sales and Growth Rate (2013-2018)
5.3 Canada Human Insulin Sales and Growth Rate (2013-2018)
5.4 Mexico Human Insulin Sales and Growth Rate (2013-2018)
6 Europe Human Insulin by Countries
6.1 Europe Human Insulin Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Insulin Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Human Insulin Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Insulin Sales and Growth Rate (2013-2018)
6.3 UK Human Insulin Sales and Growth Rate (2013-2018)
6.4 France Human Insulin Sales and Growth Rate (2013-2018)
6.5 Russia Human Insulin Sales and Growth Rate (2013-2018)
6.6 Italy Human Insulin Sales and Growth Rate (2013-2018)
7 Asia-Pacific Human Insulin by Countries
7.1 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Insulin Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Human Insulin Revenue and Market Share by Countries (2013-2018)
7.2 China Human Insulin Sales and Growth Rate (2013-2018)
7.3 Japan Human Insulin Sales and Growth Rate (2013-2018)
7.4 Korea Human Insulin Sales and Growth Rate (2013-2018)
7.5 India Human Insulin Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Insulin Sales and Growth Rate (2013-2018)
8 South America Human Insulin by Countries
8.1 South America Human Insulin Sales, Revenue and Market Share by Countries
8.1.1 South America Human Insulin Sales and Market Share by Countries (2013-2018)
8.1.2 South America Human Insulin Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Insulin Sales and Growth Rate (2013-2018)
8.3 Argentina Human Insulin Sales and Growth Rate (2013-2018)
8.4 Colombia Human Insulin Sales and Growth Rate (2013-2018)
9 Middle East and Africa Human Insulin by Countries
9.1 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Insulin Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Human Insulin Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Insulin Sales and Growth Rate (2013-2018)
9.3 UAE Human Insulin Sales and Growth Rate (2013-2018)
9.4 Egypt Human Insulin Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Insulin Sales and Growth Rate (2013-2018)
9.6 South Africa Human Insulin Sales and Growth Rate (2013-2018)
10 Global Human Insulin Market Segment by Type
10.1 Global Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Insulin Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Insulin Revenue and Market Share by Type (2013-2018)
10.2 Insulin Analogs and Biosimilars Sales Growth and Price
10.2.1 Global Insulin Analogs and Biosimilars Sales Growth (2013-2018)
10.2.2 Global Insulin Analogs and Biosimilars Price (2013-2018)
10.3 Human Insulin Biologics Sales Growth and Price
10.3.1 Global Human Insulin Biologics Sales Growth (2013-2018)
10.3.2 Global Human Insulin Biologics Price (2013-2018)
11 Global Human Insulin Market Segment by Application
11.1 Global Human Insulin Sales Market Share by Application (2013-2018)
11.2 Short acting Sales Growth (2013-2018)
11.3 Intermediate acting Sales Growth (2013-2018)
11.4 Long acting Sales Growth (2013-2018)
11.5 Pre-mix Insulin Sales Growth (2013-2018)
12 Human Insulin Market Forecast (2018-2023)
12.1 Global Human Insulin Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Insulin Market Forecast by Regions (2018-2023)
12.2.1 North America Human Insulin Market Forecast (2018-2023)
12.2.2 Europe Human Insulin Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Insulin Market Forecast (2018-2023)
12.2.4 South America Human Insulin Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Insulin Market Forecast (2018-2023)
12.3 Human Insulin Market Forecast by Type (2018-2023)
12.3.1 Global Human Insulin Sales Forecast by Type (2018-2023)
12.3.2 Global Human Insulin Market Share Forecast by Type (2018-2023)
12.4 Human Insulin Market Forecast by Application (2018-2023)
12.4.1 Global Human Insulin Sales Forecast by Application (2018-2023)
12.4.2 Global Human Insulin Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Human Insulin Picture
Table Product Specifications of Human Insulin
Figure Global Sales Market Share of Human Insulin by Types in 2017
Table Human Insul
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
